News
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...
In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
A Ghanaian-manufactured herbal-based anti-HIV drug is currently undergoing clinical trials in a potential breakthrough in the fight against the virus ...
Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...
His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results